NexGel (NXGL) Competitors $2.43 +0.20 (+8.97%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$2.42 -0.02 (-0.62%) As of 08/15/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. NTRB, VANI, CTSO, LUNG, TELA, SPAI, RBOT, SURG, CTCX, and MDAIShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Nutriband (NTRB), Vivani Medical (VANI), Cytosorbents (CTSO), Pulmonx (LUNG), TELA Bio (TELA), Safe Pro Group (SPAI), Vicarious Surgical (RBOT), SurgePays (SURG), Carmell (CTCX), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Nutriband Vivani Medical Cytosorbents Pulmonx TELA Bio Safe Pro Group Vicarious Surgical SurgePays Carmell Spectral AI NexGel (NASDAQ:NXGL) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings. Do institutionals & insiders believe in NXGL or NTRB? 2.2% of NexGel shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 20.6% of NexGel shares are held by company insiders. Comparatively, 54.1% of Nutriband shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is NXGL or NTRB more profitable? NexGel has a net margin of -25.02% compared to Nutriband's net margin of -415.93%. NexGel's return on equity of -49.37% beat Nutriband's return on equity.Company Net Margins Return on Equity Return on Assets NexGel-25.02% -49.37% -25.68% Nutriband -415.93%-68.25%-60.40% Which has more volatility and risk, NXGL or NTRB? NexGel has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, Nutriband has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Does the media refer more to NXGL or NTRB? In the previous week, NexGel had 3 more articles in the media than Nutriband. MarketBeat recorded 9 mentions for NexGel and 6 mentions for Nutriband. Nutriband's average media sentiment score of 0.48 beat NexGel's score of 0.11 indicating that Nutriband is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Nutriband 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate NXGL or NTRB? Nutriband has a consensus price target of $13.00, indicating a potential upside of 97.87%. Given Nutriband's stronger consensus rating and higher probable upside, analysts clearly believe Nutriband is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nutriband 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, NXGL or NTRB? NexGel has higher revenue and earnings than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexGel$8.69M2.26-$3.28M-$0.40-6.08Nutriband$2.14M34.23-$10.48M-$0.90-7.30 SummaryNexGel and Nutriband tied by winning 8 of the 16 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.99M$7.03B$5.68B$9.81BDividend YieldN/A1.30%3.79%4.11%P/E Ratio-6.0727.0031.0825.11Price / Sales2.2693.21466.21115.16Price / CashN/A21.7337.4059.05Price / Book3.866.529.096.18Net Income-$3.28M$178.18M$3.26B$265.11M7 Day Performance-9.67%13.90%7.36%4.21%1 Month Performance0.83%9.37%5.47%2.01%1 Year Performance-6.90%9.74%30.61%23.74% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel1.4172 of 5 stars$2.43+9.0%N/A-9.7%$17.99M$8.69M-6.0710News CoverageEarnings ReportShort Interest ↓NTRBNutriband3.2603 of 5 stars$6.74-1.6%$13.00+93.0%+7.5%$75.10M$2.14M-7.4810Short Interest ↓Gap DownVANIVivani Medical2.661 of 5 stars$1.26-0.4%$4.00+218.7%-1.6%$74.35MN/A-2.9220News CoverageEarnings ReportCTSOCytosorbents1.9393 of 5 stars$1.10-8.3%$5.50+400.0%+13.7%$69.04M$35.60M-6.47220News CoverageAnalyst RevisionGap UpLUNGPulmonx4.1697 of 5 stars$1.59+2.3%$7.66+383.6%-74.2%$64.59M$83.79M-1.11250TELATELA Bio2.7508 of 5 stars$1.62-13.0%$7.25+347.8%-48.5%$62.90M$69.30M-1.13120Earnings ReportSPAISafe Pro Group0.7461 of 5 stars$4.04+4.5%$8.00+98.3%N/A$61.00M$2.17M-4.9611Earnings ReportGap DownRBOTVicarious Surgical0.8026 of 5 stars$10.19+10.7%$8.50-16.5%+28.1%$60.63MN/A-0.98210News CoverageEarnings ReportAnalyst ForecastSURGSurgePays3.4019 of 5 stars$2.90-0.5%$9.00+210.9%+8.9%$58.58M$60.88M-1.0340News CoverageEarnings ReportAnalyst DowngradeGap UpCTCXCarmellN/A$2.70-4.6%N/A+142.3%$56.44M$32.84K0.0014Gap DownMDAISpectral AI2.9664 of 5 stars$2.22-6.1%$3.50+58.0%+27.9%$55.45M$29.58M-4.0683News CoverageEarnings ReportAnalyst DowngradeAnalyst Revision Related Companies and Tools Related Companies NTRB Alternatives VANI Alternatives CTSO Alternatives LUNG Alternatives TELA Alternatives SPAI Alternatives RBOT Alternatives SURG Alternatives CTCX Alternatives MDAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredThe Debt Crisis Is Coming—Will You Be Ready?A full-blown "economic heart attack" is coming—and the markets aren't ready. The problem? Exploding U.S. de...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.